SD, IL-13 Production Rate in IPF

Completed · Phase 2

Conditions studied: Idiopathic Pulmonary Fibrosis

In brief

The purpose of this study is to investigate how QAX576 affects levels of interleukin 13 (IL-13) in patients with idiopathic pulmonary fibrosis (IPF).

Key facts

Study ID
NCT00532233
Run by
Novartis Pharmaceuticals
People needed
52
Starts
2007-09-01
Expected to finish
2009-06-01
Last updated by the study team
2020-12-19

Who can join

Age: 40 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.